Synovial sarcoma--towards a simplified approach to prognosis

Area of Science:

• Oncology
• Orthopaedic Surgery
• Pathology

Background:

• Synovial sarcoma is an aggressive cancer primarily affecting adults.
• Identifying prognostic factors is crucial for tailoring treatment strategies.
• Previous research has explored various patient and tumor characteristics for prognostic significance.

Purpose of the Study:

• To investigate patient, tumor, and treatment characteristics influencing survival in synovial sarcoma.
• To identify specific subgroups of patients with differing prognostic outcomes.
• To enhance the understanding of prognostic indicators in synovial sarcoma.

Main Methods:

• Retrospective analysis of 25 histologically confirmed synovial sarcoma cases.
• Cox proportional hazards regression modeling to assess survival differences.
• Standardized surgical treatment by a single surgeon to minimize bias.

Main Results:

• Female sex and age under 50 were associated with statistically significant higher survival rates (P=0.040 and P=0.028, respectively).
• A trend towards improved survival was observed for upper limb tumors, smaller tumor size (<50 mm), and low nuclear grade.
• No significant differences in survival were linked to tumor differentiation, mitotic rate, necrosis, or treatment characteristics.

Conclusions:

• Confirms male sex and older age as unfavorable prognostic indicators for synovial sarcoma.
• Suggests nuclear grade assessment alone may provide a more accurate histological grading for synovial sarcoma.
• Highlights the importance of patient demographics and tumor characteristics in predicting synovial sarcoma outcomes.